T2 Biosystems to Report Second Quarter 2023 Financial Results on August 7, 2023
24 Julho 2023 - 5:05PM
T2 Biosystems, Inc. (NASDAQ:TTOO), leader in the rapid
detection of sepsis-causing pathogens and antibiotic resistance
genes, announced today that it will report financial results for
the second quarter 2023 after market close Monday, August 7, 2023.
Company management will host a corresponding conference call
beginning at 4:30 p.m. Eastern Time.
Investors interested in listening to the
conference call may do so by accessing a live and archived webcast
of the event at www.t2biosystems.com, on the Investors page in
the Events & Presentations section. To listen to the conference
call, please dial 1-888-506-0062 (US/Canada) or 1-973-528-0011
(International), passcode 420267, approximately ten to five minutes
prior to the start time.
About T2 Biosystems:T2
Biosystems, a leader in the rapid detection of sepsis-causing
pathogens and antibiotic resistance genes, is dedicated to
improving patient care and reducing the cost of care by helping
clinicians effectively treat patients faster than ever before. T2
Biosystems’ products include the T2Dx® Instrument, the T2Bacteria®
Panel, the T2Candida® Panel, the T2Resistance® Panel, and the
T2SARS-CoV-2™ Panel and are powered by the proprietary T2 Magnetic
Resonance (T2MR®) technology. T2 Biosystems has an active pipeline
of future products, including the T2Biothreat™ Panel, the Candida
auris test, and T2Lyme™ Panel, as well as next-generation products
for the detection of bacterial and fungal pathogens and associated
antimicrobial resistance markers. For more information, please
visit www.t2biosystems.com.
Investor Contact:Philip Trip Taylor, Gilmartin
Groupir@T2Biosystems.com415-937-5406
T2 Biosystems (NASDAQ:TTOO)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
T2 Biosystems (NASDAQ:TTOO)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024